Cornelia Kamp, M.B.A.

Cornelia Kamp, M.B.A.

Contact Information

Center for Human Experimental Therapeutics
Box CU 420694
265 Crittenden Blvd
Rochester, NY 14642


Ravina B, Cummings J, McDermott M, Poole M, Kamp C, Germain JM. "Study Conduct: Academic and Industry Perspectives". Clinical Trials in Neurology: From Idea to Implementation. : Cambridge University Press, 2010.
Dunn C, Chadwick G, Kamp C, Shinaman A. "Participant Recruitment and Retention in Clinical Trials". Protecting Study Volunteers in Research: A Manual for Investigative Sites. Sara Gambrill. Boston: Ken Getz, 2002. 141-149

Journal Articles

Showing all 23 journal articles available.

Dworkin, RH, Turk, TC, Katz, NP, Rowbotham MP, Peirce-Sandner S, Cerny I, Clingman CS, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sandia WS. "Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION". Pain. 2011; . Link
Dworkin, R.; Barbano, R.; Tyring, S.; Betts, R.; McDermott, M.; Pennella-Vaughan, J.; Bennett, G.; Berber, E.; Gnann, J.; Irvine, C.; Kamp, C.; Kieburtz, K.; Max, M.; Schmader, K. "A Randomized, Placebo-Controlled Trial of Oxycodone and of Gabapentin for Acute Pain in Herpes Zoster." Pain. 2009; 142: 209-217. Link
The NINDS NET-PD Investigators (Galpern, W.; MD, primary author). "A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results." Clinical Neuropharmacology. 2008; 31: 141-150. Link
Parkinson Study Group (Tanner, CM.; primary author). "Pramipexole in Levodopa Treated Parkinson's Disease Patients of African, Asian and Hispanic heritage." Clinical Neuropharmacology. 2007; 30 (2): 72-85. Link
The NINDS NET-PD Investigators (Kieburtz, K.; Primary author). "A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson's Disease." Neurology. 2007; 68: 20-28. Link
The NINDS NET-PD Investigators, NET-PD Steering Committee. "A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson's disease." Neurology. 2006; 66: 664-671. Link
Parkinson Study Group (Karen Blindauer, primary author). "Randomized placebo-controlled study of the nicotinic agonist, 51B-15084 in Parkinson's disease." Neurology. 2006; 66: 408-410. Link
Parkinson Study Group (Steven Schwid, primary author). "A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations." Arch Neurol. 2005; 62: 241-248. Link
Elm J, Goetz C, Ravina B, Shannon K, Wooten F, Tanner C, Palesch Y, Huang P, Guimaraes P, Kamp C, Tilley B, Kieburtz K, for the NET-PD Investigators. "A Responsive Outcome for Parkinson's Disease Neuroprotection Futility Studies." Annals of Neurology. 2005; 57(2): 197-203. Link
Comella CL, Jankovic J, Shannon KM, et al. "A Comparison of botulinum toxin serotypes A and B for the treatment of Cervical Dystonia." Neurology. 2005; 65: 1423-1429. Link
Parkinson Study Group (Steven Schwid, primary author). "The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD." Neurology. 2004; 62: 330-332. Link
Parkinson Study Group (Robert Holloway, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease: A 4-year Randomized Controlled Trial." Arch Neurol. 2004; 61(7): 1044-1053. Link
Noyes K, Dick A, Holloway RG, and the Parkinson Study Group. "Pramipexole vs Levodopa as Initial Treatment for Parkinson's Disease. A Randomized Clinical-economic Trial." Med Decis Making. 2004; 2004: 472-485. Link
Holloway, RG.; Shouldson, I.; Fahn, S.; Kieburtz, K.; Lang, A.; Marek, K.; McDermott, M.; Seibyl, J.; Weiner, W.; Musch, B.; Kamp, C.; et. al..; Parkinson Study Group. "Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial." Arch Neurol.. 2004; 61(7): 1044-53. Link
Parkinson Study Group (Karen Blindauer, primary author). "A Controlled Trial of rotigotine Monotherapy in Early Parkinson's Disease." Arch Neurol. 2003; 60: 1721:1728. Link
Parkinson Study Group (Kenneth Marek, primary author). "Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression." JAMA. 2002; 287 (13): 1653-1661. Link
Sacktor, N.; Schifitto, G.; McDermott, MP.; Marder, K.; McArthur, JC.; Kieburtz, K. "Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study." Neurology. 2000; 54: 233-235. Link
Parkinson Study Group (Holloway R, primary author). "Pramipexole vs levodopa as initial treatment for Parkinson disease. A randomized controlled trial." JAMA. 2000; 284: 1931-1938. Link
Parkinson Study Group. "A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: Design and methods of the CALM-PD study." Clinical Neuropharmacology. 2000; 23: 34-44. Link
Schifitto, G.; Sacktor, N.; Marder, K.; McDermott, M.; McArthur, JC.; Kieburtz , K.; et al. "Randomized trial of the PAF antagonist lexipafant in HIV-associated cognitive impairment." Neurology. 1999; 53: 391-396. Link
The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders (N Sacktor, primary author). "A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment." Neurology. 1998; 50: 645-651. Link
Rifai, Z.; Kazee, AM.; Kamp, C.;, Griggs, RC. "Intranuclear rods in severe congenital nemaline myopathy." Neurology. 1993; 43: 2372-2377. Link
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I and the PSG PRECEPT Investigators. "Cancer incidence in a trial of an anti-apoptotic agent for Parkinson's Disease." Mov Dis. . Link